![]() |
Volumn 53, Issue , 2002, Pages 173-188
|
The expanding pharmacopoeia for bipolar disorder
|
Author keywords
Carbamazepine; Lamotrigine; Mood stabilizers; Olanzapine; Valproate
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CARBAMAZEPINE;
CLOZAPINE;
GABAPENTIN;
LAMOTRIGINE;
LITHIUM;
MARCKS PROTEIN;
NEUROLEPTIC AGENT;
OLANZAPINE;
PROTEIN KINASE C;
RISPERIDONE;
TAMOXIFEN CITRATE;
TOPIRAMATE;
VALPROATE SEMISODIUM;
VALPROIC ACID;
CHEMOPROPHYLAXIS;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DEPRESSION;
DRUG CHOICE;
DRUG EFFICACY;
DRUG SAFETY;
FETOTOXICITY;
HUMAN;
MANIA;
MANIC DEPRESSIVE PSYCHOSIS;
MOOD;
OVARY POLYCYSTIC DISEASE;
PREGNANCY;
PRIORITY JOURNAL;
RASH;
REVIEW;
STEVENS JOHNSON SYNDROME;
ANTICONVULSANTS;
ANTIMANIC AGENTS;
ANTIPSYCHOTIC AGENTS;
BIPOLAR DISORDER;
CLINICAL TRIALS;
DRUG THERAPY, COMBINATION;
HUMANS;
PHARMACOPOEIAS;
UNITED STATES;
|
EID: 0036183555
PISSN: 00664219
EISSN: None
Source Type: Book Series
DOI: 10.1146/annurev.med.53.082901.103933 Document Type: Review |
Times cited : (56)
|
References (74)
|